Your browser doesn't support javascript.
loading
Edaravone Administered Orally and Via Nasogastric Tube in Healthy Adults: A Comparative Bioavailability Phase 1 Study.
Shimizu, Hidetoshi; Nishimura, Yukiko; Shiide, Youichi; Ueda, Masaki; Yokota, Shoko; Kato, Yuichiro; Hirai, Manabu.
Affiliation
  • Shimizu H; Clinical Pharmacology Group, Data Science Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Nishimura Y; Clinical Research & Development I Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Shiide Y; Clinical Research & Development I Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Ueda M; Clinical Research & Development I Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Yokota S; Data Analytics Group, Data Science Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Kato Y; Biostatistics Group, Data Science Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Hirai M; Clinical Research & Development I Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
Clin Pharmacol Drug Dev ; 12(1): 77-84, 2023 01.
Article in En | MEDLINE | ID: mdl-36225132
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Intubation, Gastrointestinal Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Intubation, Gastrointestinal Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2023 Document type: Article